Climb Bio (CLYM) Non Operating Income (2024 - 2026)
Climb Bio's (CLYM) quarterly Non Operating Income came in at $1.5 million in Q1 2026, down 33.44% YoY from $2.2 million in Q1 2025, and down 25.7% on a QoQ basis from $2.0 million in Q3 2025.
Powered by 
Analysis
Climb Bio (CLYM) Non Operating Income (2024 - 2026) Analysis & Trends
Climb Bio (CLYM) has 3 years of Non Operating Income data on file, last reported at $1.5 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | -139.24 Mn |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | -53.64 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | -51.63 Mn |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | - |
| 10 | Climb Bio | 1.17 Bn | 1.17 Bn | - | 1.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.86 Mn |
| Mar 31, 2026 | 1.49 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 2.01 Mn |
| Mar 31, 2025 | 2.24 Mn |
| Sep 30, 2024 | 2.84 Mn |
| Jun 30, 2024 | 1.48 Mn |